2026 Q2 Portfolio Activity
In 2026 Q2, ABG-WTT Global Life Science Capital Partners GP Ltd maintained a portfolio of 2 distinct positions. The fund also reduced its exposure to CERIBELL INC by 37.7%.
Position History
hover any row below to update
Loading…
Total Positions
2
Quarter
2026 Q2
Top Holding
CBLL (62.6%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-2 of 2
ABG-WTT Global Life Science Capital Partners GP Ltd Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CBLL
CERIBELL INC
|
Healthcare | 62.61% | 65.87% |
#1
Prev: #1
|
6.0 |
—
|
-166,492 | -37.7% |
P
S
|
275,328 | $5,355,130 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RPID
RAPID MICRO BIO...
|
Healthcare | 37.39% | 34.13% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
1,848,296 | $3,197,552 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-2 of 2 holdings